Biogen Idec Inc. (NASDAQ:BIIB) mean price target has been set at $333.6000 by Thomson Reuters. The group worked out on the stock recommendations given by analysts in the First Call poll. Further, it is possible that the company may register per share earnings of $5.0800 in the near-term quarter and $19.9800 for the ongoing fiscal. The market cap of Biogen Inc. was recorded at $68.95B after the stock closed at $313.6500 in last trading day.
What The Valuation Says?
The price/earnings ratio is taken in the list of ratios that leads to a stock’s valuation. Commonly named as P/E ratio, it helps investors know where the company stands in the market. It is derived by dividing share’s latest price by per-share earnings. Biogen Idec Inc. (NASDAQ:BIIB) has a P/E ratio of 18.3821. Investors can identify how the stock is doing in the market by estimating Price-to-Earnings Growth ratio.
Biogen Idec Inc. (NASDAQ:BIIB) PEG ratio sits at 1.6500. A low PEG ratio offers an investment opportunity to the opportunistic traders and investors. In case a stock has a reading in between 0 and 1, it represents undervalued stock. A reading of 1 and 2 represents fairly priced stocks.
The technical analysis of Biogen Inc. visibly illustrates that the 50-day MA of Biogen Inc. is $265.8000, and stock is trading $48.8825 points away or +18.3907% from its 50-day moving average of $265.8000. Further it is trading $49.8465 or +18.8216% away its 200-day moving average of $264.8360. Biogen Idec Inc. (NASDAQ:BIIB) 52-week high is $333.6500 and the 52-week low is $223.0200. This represents that if the stock moves $-18.9675 points up on the chart to it will make a 52-week high. But, if it declines +41.1006%, then the shares price can hit a new 52-week low.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...